BioCompounding BioCompounding
  • Home
  • About Us
  • Why BioCompounding
  • Technologies in 5 mins
  • Deep Dives
Subscribe
Technologies in 5 mins

The race to sequence the world - A look at Next Generation Sequencing (NGS)

Biocompounding

Biocompounding

Mar 22, 2023 7 min
The race to sequence the world - A look at Next Generation Sequencing (NGS)
Photo by D koi / Unsplash

This post is for subscribers only

Subscribe now

Already have an account? Sign in

Read next

Generics vs. Biosimilars: Why They're Not the Same Business

Generics vs. Biosimilars: Why They're Not the Same Business

Generics and biosimilars have the same goal: cheaper versions of drugs whose patents have expired. That is where the similarity ends. A generic is a commodity. It copies a small-molecule drug made by simple chemistry, and the copy is identical to the original. Because anyone can make it, many
Biocompounding Oct 12, 2026
An Overview of ADC Therapeutic's in Oncology

An Overview of ADC Therapeutic's in Oncology

Part 1: Exploring ADC functionality and an overview of FDA-approved oncology treatments As part of the expansion from our “Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy” article, we have previously described how Chimeric Antigen Receptor (CAR)-T cell therapies are used to treat various types
Biocompounding Oct 20, 2024
From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

Biocompounding Apr 28, 2024

Subscribe to BioCompounding

Understand the healthcare companies that will compound for a decade. Deep dives for long-term investors who aren’t biologists.
  • Sign up
  • Disclaimer
  • Collaboration & Partnership
BioCompounding © 2026. Powered by Ghost